© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
March 31, 2021
Despite significant decreases in 2020, a large number of adolescents less than 18 years of age continue to use e-cigarettes, with considerable adverse health effects, according to a presentation at the 2021 National Association of Pediatric Nurse Practitioners (NAPNAP) conference.
February 25, 2021
The approval makes adalimumab the only subcutaneous biologic for pediatric patients with ulcerative colitis that can be administered at home.
February 10, 2021
First approved by the FDA in 1989 for 2 rare eye muscle disorders, onabotulinumtoxinA (Botox; Allergan) was the world’s first approved botulinum toxin type A treatment.
February 03, 2021
Push continues for more access to EpiPens, but it is important to protect health care providers who administer the treatment.
November 03, 2020
Data show that children with cancer who are experiencing neighborhood poverty and rely on public health insurance have an increased risk of death with stem cell treatment.
September 02, 2020
Clinicians often reserve vigilance with drug-related issues for critically ill patients or older populations, while mistaking the resilience of childhood as a protective barrier.
August 23, 2020
A table showing recommended immunization schedules for child and adolescent patients.
August 21, 2020
Pharmacy Times spoke with Suzanne Soliman, PharmD, BCMAS, about how pharmacists can prepare their patients for the back-to-school season amid the COVID-19 pandemic and the upcoming flu season.
August 16, 2020
Pharmacy Times will continue to bring readers the latest information on COVID-19 developments, in a variety of formats.
August 10, 2020
Risdiplam is the first at-home, orally administered treatment for spinal muscular atrophy in adults and children aged 2 months and older.